Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment
GRACE
1 other identifier
interventional
700
1 country
1
Brief Summary
Investigators will conduct a pragmatic randomized trial to investigate the non-inferiority of restricted use of invasive arterial lines compared to standard arterial line use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2022
CompletedFirst Posted
Study publicly available on registry
June 9, 2022
CompletedStudy Start
First participant enrolled
October 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2023
CompletedFebruary 26, 2024
February 1, 2024
9 months
June 6, 2022
February 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of days hospitalized in the medical intensive care unit (length-of-stay)
Number of days hospitalized in the medical intensive care unit
inpatient hospitalization (approximately 1 to 30 days)
Secondary Outcomes (12)
Number of days hospitalized in a non- medical intensive care unit (Hospital length-of-stay)
inpatient hospitalization (approximately 1 to 30 days)
Number of days using a mechanical ventilator (Ventilator-days)
inpatient hospitalization (approximately 1 to 30 days)
Number of days using vasopressor medicines (vasopressor-days)
inpatient hospitalization (approximately 1 to 30 days)
Number of blood transfusions received during hospitalization (packed red blood cell transfusions)
inpatient hospitalization (approximately 1 to 30 days) and receiving approximately 0 - 10 blood transfusions
Number of participants experiencing a bloodstream infection related to invasive arterial catheter use
inpatient hospitalization (approximately 1 to 30 days) and experiencing 0 to 1 bloodstream infections
- +7 more secondary outcomes
Study Arms (2)
Restricted-use of arterial catheters
EXPERIMENTALStandard-use of arterial catheters
ACTIVE COMPARATORInterventions
The investigator will restrict the use of arterial catheters unless exclusion criteria is met.
The investigator will allow standard-use of arterial catheters
Eligibility Criteria
You may qualify if:
- All subjects admitted to the medical intensive care unit
- All subjects \<18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Feller-Kopman, MD
Dartmouth-Hitchcock Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine, Geisel School of Medicine Chief, Pulmonary and Critical Care Medicine
Study Record Dates
First Submitted
June 6, 2022
First Posted
June 9, 2022
Study Start
October 17, 2022
Primary Completion
July 14, 2023
Study Completion
July 14, 2023
Last Updated
February 26, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share